Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002546)

(Analysis AN004193)

Metabolite	Structure	F1	F2
Ceramide (d42:2) B	ME617284	NA	1.00
PC (40:4)	ME617364	1.19	0.81
PC (40:5) B	ME617366	1.18	0.82
Ceramide (d34:0)	ME617274	1.18	0.82
Ceramide (d34:1)	ME617275	1.18	0.82
Ceramide (d42:0)	ME617281	1.23	0.77
SM (d34:0)	ME617401	1.22	0.78
SM (d34:1)	ME617402	1.22	0.78
PE (38:2)	ME617387	0.98	1.02
PE (p-38:4) or PE (o-38:5)	ME617394	0.99	1.01
PC (36:2)	ME617350	1.00	1.00
PE (36:2)	ME617384	1.00	1.00
PC (38:4) A	ME617360	1.02	0.98
GlcCer (d42:2)	ME617316	1.02	0.98
PC (36:1)	ME617349	1.02	0.98
SM (d33:1)	ME617400	1.01	0.99
PE (38:6)	ME617389	1.01	0.99
PC (p-42:4) or PC (o-42:5)	ME617382	1.01	0.99
PC (38:3)	ME617359	1.01	0.99
PC (38:5) A	ME617361	1.01	0.99
GlcCer (d42:1)	ME617315	1.03	0.97
PC (p-34:0) or PC (o-34:1)	ME617371	1.03	0.97
PC (32:0)	ME617336	1.04	0.96
PC (36:5) B	ME617356	1.04	0.96
PC (34:0)	ME617341	1.05	0.95
PE (p-36:4) or PE (o-36:5)	ME617393	1.06	0.94
LPC (18:0) A	ME617321	1.06	0.94
LPC (18:0) B	ME617322	1.06	0.94
Ceramide (d40:0)	ME617277	1.07	0.94
LPC (22:5)	ME617328	1.07	0.93
SM (d36:2)	ME617405	1.10	0.93
SM (d42:2) B	ME617414	1.08	0.92
FA (20:3) (eicosatrienoic acid)	ME617301	1.08	0.92
PE (38:4) B	ME617388	1.08	0.92
SM (d41:1)	ME617413	1.09	0.91
SM (d38:1)	ME617407	1.09	0.91
PC (40:5) A	ME617365	1.09	0.91
SM (d36:1)	ME617404	1.09	0.91
PE (p-38:5) or PE (o-38:6)	ME617395	1.14	0.86
FA (8:0) (caprylic acid)	ME617311	1.12	0.88
PC (38:5) B	ME617362	1.11	0.89
PC (40:6) B	ME617367	1.11	0.89
GlcCer (d38:1)	ME617313	0.81	1.19
PE (p-36:2) or PE (o-36:3)	ME617392	0.82	1.18
PC (34:4)	ME617345	0.82	1.18
FA (20:3) (homo-gamma-linolenic acid)	ME617302	0.82	1.18
LPE (20:4)	ME617331	0.82	1.18
FA (20:2) (eicosadienoic acid)	ME617300	0.84	1.16
LysoPC 20:4;	ME617334	0.84	1.16
PC (p-36:4) or PC (o-36:5)	ME617376	0.83	1.17
PC (p-34:2) or PC (o-34:3)	ME617374	0.83	1.17
LPE (18:2)	ME617330	0.83	1.17
PC (35:4)	ME617348	0.83	1.17
SM (d40:1)	ME617409	0.87	1.13
PC (36:3) B	ME617352	0.87	1.13
PC (33:1)	ME617339	0.87	1.13
PC (32:2)	ME617338	0.87	1.13
LPE (22:6)	ME617332	0.87	1.13
Ceramide (d38:1)	ME617276	0.87	1.13
FA (18:3) (linolenic acid)	ME617297	0.87	1.13
PC (36:5) A	ME617355	0.88	1.12
LPC (18:2)	ME617324	0.88	1.12
LPC (18:1)	ME617323	0.88	1.12
FA (18:1) (oleic acid)	ME617295	0.88	1.12
FA (15:1)	ME617291	0.88	1.12
FA (17:0) (margaric acid)	ME617293	0.88	1.12
SM (d39:1)	ME617408	0.86	1.14
PC (p-34:1) or PC (o-34:2) B	ME617373	0.86	1.14
PC (40:8)	ME617369	0.86	1.14
FA (22:0) (behenic acid)	ME617305	0.86	1.14
Ceramide (d42:2) A	ME617283	0.86	1.14
FA (14:0) (myristic acid)	ME617288	0.86	1.14
FA (22:6) (docosahexaenoic acid)	ME617308	0.85	1.15
FA (24:1) (nervonic acid)	ME617310	0.85	1.15
PC (p-32:0) or PC (o-32:1)	ME617370	0.95	1.05
PC (37:4)	ME617358	0.95	1.05
PC (36:3) A	ME617351	0.95	1.05
EtherPE 40:6e; PE(18:0e/22:6);	ME617287	0.95	1.05
LPC (20:2)	ME617326	0.95	1.05
SM (d36:3)	ME617406	0.96	1.04
PC (p-38:4) or PC (o-38:5) B	ME617379	0.96	1.04
PC (p-36:3) or PC (o-36:4)	ME617375	0.96	1.04
Ceramide (d42:1)	ME617282	0.96	1.04
EtherPE 38:4e; PE(18:0e/20:4);	ME617286	0.96	1.04
Ceramide (d43:1)	ME617285	0.97	1.03
PC (40:7)	ME617368	0.97	1.03
PE (p-40:6) or PE (o-40:7)	ME617397	0.92	1.08
PE (34:2)	ME617383	0.92	1.08
PC (36:4) A	ME617353	0.92	1.08
PC (32:1)	ME617337	0.92	1.08
PC (35:1)	ME617346	0.92	1.08
PI 38:4; PI(18:0/20:4);	ME617398	0.93	1.07
LPE (16:0)	ME617329	0.93	1.07
LPC (16:0)	ME617319	0.93	1.07
FA (20:4) (arachidonic acid)	ME617303	0.93	1.07
FA (24:0) (lignoceric acid)	ME617309	0.93	1.07
SM (d34:2)	ME617403	0.94	1.06
GlcCer(d14:1(4E)/20:0(2OH))	ME617317	0.94	1.06
PC (34:1)	ME617342	0.94	1.06
PE (36:3)	ME617385	0.89	1.11
PC (p-40:4) or PC (o-40:5)	ME617381	0.89	1.11
FA (20:5) (eicosapentaenoic acid)	ME617304	0.89	1.11
PC (36:4) B	ME617354	0.89	1.11
PC (p-38:4) or PC (o-38:5) A	ME617378	0.91	1.09
PC (38:6)	ME617363	0.91	1.09
PC (34:2)	ME617343	0.91	1.09
LysoPC 22:6;	ME617335	0.91	1.09
LPC (14:0)	ME617318	0.91	1.09
Ceramide (d41:1)	ME617280	0.91	1.09
FA (18:2) (linoleic acid)	ME617296	0.91	1.09
SM (d40:3)	ME617412	0.90	1.10
SM (d32:1)	ME617399	0.90	1.10
PE (p-38:6) or PE (o-38:7)	ME617396	0.90	1.10
PE (p-36:1) or PE (o-36:2)	ME617391	0.90	1.10
PE (36:4)	ME617386	0.90	1.10
PC (p-40:3) or PC (o-40:4)	ME617380	0.90	1.10
PC (35:2)	ME617347	0.90	1.10
PC (p-38:3) or PC (o-38:4)	ME617377	0.90	1.10
FA (17:1) (heptadecenoic acid)	ME617294	0.72	1.28
FA (22:1) (erucic acid)	ME617306	0.72	1.28
PC (37:2)	ME617357	0.71	1.29
SM (d40:2) A	ME617410	0.71	1.29
LPC (20:1)	ME617325	0.70	1.30
Ceramide (d40:1)	ME617278	0.69	1.31
FA 19:0;	ME617312	0.68	1.32
PE (p-34:2) or PE (o-34:3)	ME617390	0.73	1.23
FA (20:0) (arachidic acid)	ME617298	0.75	1.25
FA (14:1) (physeteric acid)	ME617289	0.75	1.25
FA (16:1) (palmitoleic acid)	ME617292	0.75	1.25
PC (34:3)	ME617344	0.80	1.20
PC (p-34:1) or PC (o-34:2) A	ME617372	0.78	1.22
FA (15:0) (pentadecylic acid)	ME617290	0.78	1.22
LPC (20:3)	ME617327	0.78	1.22
SM (d40:2) B	ME617411	0.77	1.23
LPC (16:1)	ME617320	0.77	1.23
PC (33:2)	ME617340	0.77	1.23
Ceramide (d40:2)	ME617279	0.55	1.45
LysoPC 20:0;	ME617333	0.56	1.44
GlcCer (d40:1)	ME617314	0.62	1.38
FA (20:1) (eicosenoic acid)	ME617299	0.65	1.35
FA (22:2) (docosadienoic acid)	ME617307	0.64	1.36

Factors:

F1	Factor:Infected
F2	Factor:Uninfected

Data matrix